Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
about
HITlights: a career perspective on heparin-induced thrombocytopeniaHeparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit.Pathobiology of secondary immune thrombocytopenia.Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.Mesenteric and coeliac occlusions following heparin-induced thrombocytopenia after aortobiprofunda bypass surgery.Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays.Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.HIT paradigms and paradoxes.Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit.Evaluation of two new automated chemiluminescent assays (HemosIL® AcuStar HIT-IgG and HemosIL® AcuStar HIT-Ab) for the detection of heparin-induced antibodies in the diagnosis of heparin-induced thrombocytopenia.Management of heparin-induced thrombocytopenia.Dynamic antibody-binding properties in the pathogenesis of HIT.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.A Rare Case of Acute Myocardial Infarction due to Coronary Artery Dissection and Heparin-Induced Thrombocytopenia.Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.Evaluation of a pretest scoring system (4Ts) for the diagnosis of heparin-induced thrombocytopenia in a university hospital setting.Novel diagnostic assays for heparin-induced thrombocytopeniaFcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.Heparin induced thrombocytopenia: review.Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.Production of Anti-platelet Factor 4/Heparin Complex Antibodies After Cardiovascular Surgery.Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.Design of the rivaroxaban for heparin-induced thrombocytopenia study.Platelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.Thrombocytopenia: an update.
P2860
Q26828351-2BF23872-30B3-4062-8C1E-B7178531DA03Q33380320-BAEAA01A-AA97-4DAE-9810-3A5BA6B83180Q33383468-FC3755AB-7165-4684-A225-DC4CB5839013Q33385134-636A633C-6FFC-4093-A8AD-F1F3A2040313Q33385510-F61969FD-C85D-4C41-A1B1-CD6D278CE5F8Q33386621-DD4805AA-3BC2-419B-B980-9B625FE5957DQ33387758-9C90FCAB-6009-4C6D-9740-78E3795283C5Q33389839-EF8EDF43-77B9-4025-A324-068CDB2135FAQ33393048-3EE75DEF-879B-4ECE-8620-3961D3D3E368Q33393683-745DDF85-4386-4BD7-84BF-DF268002B8FDQ33394188-C83CCA7B-7134-4AA7-B0D6-2BB4ACBF3929Q33395782-2605DAB7-73F2-470C-9319-0220C8A68601Q33396313-6B7046D9-27EC-44A0-97CC-BB5B551A0079Q33396967-A7BD6BF6-FB14-48D2-85CA-66BAF5E2F3DCQ33397294-96BFAAE6-4F8F-497A-BA0C-959692470C27Q33399580-3EB70223-778B-4710-B7DB-6963FFFCD65EQ33400056-E4010DB7-4DDE-4D70-B51F-235D9F0D19A9Q33400181-3A200D4E-CDA9-4C5D-B7C6-9D1677FCA1B6Q33400573-D76FD5A1-21A8-43AB-BD6A-C104A2295578Q33401163-D87E8D3A-7DB1-443D-984B-A768D8099392Q33401466-B28305EB-DCD6-4B42-AA0E-E5E8A5E82316Q33401903-EC04B8D2-88EA-409C-9933-E55489A5FBFCQ33402336-5A4D89EC-203A-42AE-9489-AFC8801AB4AAQ33402572-D1B5BB63-A0AF-4AB6-B969-697AAC52F8F7Q33403113-FDE86080-4450-4E56-8AD9-C116BC0341B6Q33405315-7A98D22B-AB5A-4934-856E-97AC4E3CCC45Q33406133-E6396E0A-363E-4765-B3B2-B9AF971F1702Q33406804-11147010-69A1-485E-83B4-0900906C19EAQ33406904-5BB25C60-F6E6-474C-91A6-F6D65AF308E3Q33407198-CBF91A58-BE47-4F16-B956-39E9133A8009Q33407497-DA52049C-99E3-48F8-9C04-DE028D9AB975Q33409277-F02371D1-21E8-47CE-833B-70FA4FFBE025Q33410083-19F2794D-C91B-4958-88E6-D9682E9057D7Q33410242-5B0271BC-9DFA-471B-95FA-B75D7161A3CEQ33411333-BA0DCDF7-BCA5-4BFC-86A1-270173FD92C5Q33411785-4333A61F-3B0B-4E2A-B777-023057ECF74AQ33413409-29629D4A-5B41-410A-B4D9-37B62CEE9728Q33413476-E9E8437F-BA74-488C-B687-098FD60E986AQ33414139-9D8A6F03-4EB1-4194-A5A9-65FA1DD2C3C4Q33414744-B2DDFCC0-3FD8-433D-8D7C-FE9B1504BB1B
P2860
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@ast
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@en
type
label
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@ast
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@en
prefLabel
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@ast
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@en
P2093
P1476
Quantitative interpretation of ...... dependent enzyme-immunoassays.
@en
P2093
C S Sigouin
J G Kelton
J I Sheppard
P304
P356
10.1111/J.1538-7836.2008.03025.X
P577
2008-05-17T00:00:00Z